Answers are grounded in this paper and cite their sources.
Letters6 November 2001Treatment of Refractory Erdheim–Chester Disease with Double Autologous Hematopoietic Stem-Cell TransplantationNicolas Boissel, MD, Bertrand Wechsler, MD, and Véronique Leblond, MDNicolas Boissel, MDGroupe Hospitalier Pitié-Salpêtrière; 75013 Paris, France (Boissel, Wechsler, Leblond), Bertrand Wechsler, MDGroupe Hospitalier Pitié-Salpêtrière; 75013 Paris, France (Boissel, Wechsler, Leblond), and Véronique Leblond, MDGroupe Hospitalier Pitié-Salpêtrière; 75013 Paris, France (Boissel, Wechsler, Leblond)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-135-9-200111060-00027 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Erdheim–Chester disease is a non-Langerhans form of histiocytosis with a grim prognosis, especially in cases of extraosseous involvement. Several treatments similar to those used in Langerhans cell histiocytosis have been tried, but with little effect (1, 2).An 18-year-old man presented with exophthalmos and bone pain. Exophthalmometry values were 32/28 mm for the right and left eyes, respectively (Figure). Proptosis and deterioration of visual acuity (20/200 and 20/25) were noted. Radiography showed bilateral tibial osteosclerosis. Technetium-99 bone scanning showed several sites of increased labeling. Cerebral magnetic resonance imaging disclosed a voluminous facial mass that involved both orbits ...References1. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, et al . Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore). 1996;75:157-69. [PMID: 0008965684] CrossrefMedlineGoogle Scholar2. Miller RL, Sheeler LR, Bauer TW, Bukowski RM. Erdheim-Chester disease. Case report and review of the literature. Am J Med. 1986;80:1230-6. [PMID: 0003728520] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Groupe Hospitalier Pitié-Salpêtrière; 75013 Paris, France (Boissel, Wechsler, Leblond) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByTherapy of 3 patients with Erdhiem-Chester disease with cladribin or cladribin in combination with cyclophosphamide. Case report and review of the therapyErdheim-Chester disease: a comprehensive review from the ophthalmologic perspectiveErdheim–Chester diseaseErdheim–Chester disease. Literature review and clinical caseErdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular eraJuvenile Xanthogranuloma and Other Non‐Langerhans Cell HistiocytosesResolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester diseaseErdheim-Chester DiseaseIntérêt de la médecine nucléaire dans la maladie d'Erdheim-Chester : une expérience lilloiseErdheim-Chester Disease and Other HistiocytosesLa maladie d'Erdheim-Chester, une néoplasie myéloïde inflammatoireRapid progression to cardiac tamponade in Erdheim–Chester disease despite treatment with interferon alphaA Unique Case of Erdheim-Chester Disease with Axial Skeleton, Lymph Node, and Bone Marrow InvolvementThe histiocytosis Erdheim–Chester disease is an inflammatory myeloid neoplasmMultiple cutaneous, oropharyngeal and pulmonary nodulesErdheim-Chester diseaseNon-langerhans Cell Histiocytosis-Including Erdheim-Chester Disease- and the LungClinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case seriesMaladie d'Erdheim-ChesterConsensus guidelines for the diagnosis and clinical management of Erdheim-Chester diseaseErdheim-Chester Disease: Characteristics and ManagementErdheim–Chester DiseaseSuccessful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist proteinSuccès du traitement d'une maladie d'Erdheim-Chester par l'inhibiteur du récepteur de l'interleukine-1En mann i 40-årene med hevelse i begge øyehulerStrategies and treatment alternatives in the management of Erdheim–Chester diseaseErdheim-Chester DiseaseFavorable radiological outcome of skeletal Erdheim-Chester disease involvement with anakinraÉvolution radiologique favorable d'atteinte osseuse d'une maladie d'Erdheim-Chester sous anakinraBilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literatureTreatment of Erdheim-Chester Disease with Long-Term High-Dose Interferon-αA Case of Erdheim-Chester Disease with Asymptomatic Renal InvolvementErdheim–Chester disease: The role of video-assisted thoracoscopic surgery in diagnosing and treating cardiac involvementErdheim–Chester diseaseLangerhans cell histiocytosis and Erdheim–Chester diseaseTreatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugsHistiocytosisCNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patientsSystemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patientsRationale and efficacy of interleukin-1 targeting in Erdheim–Chester diseasePulmonary involvement in Erdheim-Chester disease: A single-center study of thirty-four patients and a review of the literatureErdheim-Chester-Erkrankung der Orbita mit KompressionsneuropathieDoença de Erdheim-Chester: relato de dois casosErdheim-Chester diseaseA Case of Erdheim-Chester Disease Who Has Policythemia VeraMaladie d'Erdheim-ChesterVariability in the efficacy of interferon-α in Erdheim-Chester disease by patient and site of involvement: Results in eight patientsPalliative treatment of Erdheim–Chester disease with radiotherapy: A Rare Cancer Network studySuccessful treatment of Erdheim-Chester disease, a non–Langerhans-cell histiocytosis, with interferon-αErdheim?Chester disease of the breast associated with Langerhans-cell histiocytosis of the hard palateErdheim-Chester Disease: Clinical and Pathologic Spectrum of Four Cases From the Arkadi M. Rywlin Slide Seminars 6 November 2001Volume 135, Issue 9Page: 844-845KeywordsBloodBoneCellsMagnetic resonance imagingOsteocalcinProteinsRenal diseasesSteroidsTransplantationVisual acuity ePublished: 6 November 2001 Issue Published: 6 November 2001 CopyrightCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
Boissel et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: